Capital World Investors Vertex Pharmaceuticals Inc Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital World Investors holds 25,567,184 shares of VRTX stock, worth $12.1 Billion. This represents 1.82% of its overall portfolio holdings.

Number of Shares

25,567,184

Previous 21,805,770 17.25%

Holding current value

$12.1 Billion

Previous $8.87 Billion 20.45%

% of portfolio

1.82%

Previous 1.62%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $1.53 Billion - $1.68 Billion	3,761,414 Added 17.25%	25,567,184 $10.7 Billion
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $1.31 Billion - $1.57 Billion	3,824,103 Added 21.27%	21,805,770 $8.87 Billion
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $217 Million - $232 Million	641,033 Added 3.7%	17,981,667 $6.25 Billion
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $376 Million - $421 Million	1,196,211 Added 7.41%	17,340,634 $6.1 Billion
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $956 Million - $1.09 Billion	3,375,417 Added 26.43%	16,144,423 $5.09 Billion

Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $69.8 Million - $78.5 Million	244,327 Added 1.95%	12,769,006 $3.69 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $12.4 Million - $13.8 Million	-45,253 Reduced 0.36%	12,524,679 $3.63 Billion
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $22.6 Million - $28.1 Million	-96,198 Reduced 0.76%	12,569,932 $3.54 Billion
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $254 Million - $299 Million	1,145,275 Added 9.94%	12,666,130 $3.31 Billion
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $84.7 Million - $107 Million	478,553 Added 4.33%	11,520,855 $2.53 Billion
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $4.88 Million - $5.47 Million	26,924 Added 0.24%	11,042,302 $2 Billion
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $255 Million - $300 Million	1,357,903 Added 14.06%	11,015,378 $2.22 Billion
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $687,306 - $801,149	3,320 Added 0.03%	9,657,475 $2.08 Billion
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $353 Million - $471 Million	-1,706,360 Reduced 15.02%	9,654,155 $2.28 Billion
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $288 Million - $342 Million	-1,127,728 Reduced 9.03%	11,360,515 $3.09 Billion
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $20.6 Million - $27.1 Million	-91,475 Reduced 0.73%	12,488,243 $3.63 Billion
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $396 Million - $491 Million	1,981,607 Added 18.7%	12,579,718 $2.99 Billion
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $1.88 Million - $2.53 Million	11,278 Added 0.11%	10,598,111 $2.32 Billion
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $143 Million - $161 Million	-862,721 Reduced 7.53%	10,586,833 $1.79 Billion
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $88.2 Million - $102 Million	535,827 Added 4.91%	11,449,554 $2.1 Billion
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $169 Million - $201 Million	1,033,361 Added 10.46%	10,913,727 $2.01 Billion
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $331 Million - $419 Million	2,181,475 Added 28.33%	9,880,366 $1.64 Billion
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $552 Million - $635 Million	-3,293,143 Reduced 29.96%	7,698,891 $1.48 Billion
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $290 Million - $339 Million	1,993,107 Added 22.15%	10,992,034 $1.87 Billion
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $471 Million - $551 Million	3,109,444 Added 52.8%	8,998,927 $1.47 Billion
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $779 Million - $882 Million	-5,672,358 Reduced 49.06%	5,889,483 $883 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $1.71 Billion - $1.88 Billion	11,561,841	11,561,841 $1.76 Billion

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Vertex Pharmaceuticals Inc Transaction History